As of 2025-08-08, the Intrinsic Value of Genesis Healthcare Inc (GEN) is 31.65 USD. This GEN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 28.27 USD, the upside of Genesis Healthcare Inc is 11.90%.
The range of the Intrinsic Value is 22.25 - 49.91 USD
Based on its market price of 28.27 USD and our intrinsic valuation, Genesis Healthcare Inc (GEN) is undervalued by 11.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 22.25 - 49.91 | 31.65 | 11.9% |
| DCF (Growth 10y) | 29.40 - 59.29 | 39.63 | 40.2% |
| DCF (EBITDA 5y) | 17.37 - 24.26 | 21.93 | -22.4% |
| DCF (EBITDA 10y) | 24.90 - 33.92 | 30.35 | 7.3% |
| Fair Value | 5.18 - 5.18 | 5.18 | -81.66% |
| P/E | 17.91 - 26.13 | 21.22 | -24.9% |
| EV/EBITDA | 16.54 - 24.15 | 21.72 | -23.2% |
| EPV | 14.23 - 19.85 | 17.04 | -39.7% |
| DDM - Stable | 8.32 - 20.59 | 14.45 | -48.9% |
| DDM - Multi | 12.54 - 23.10 | 16.16 | -42.9% |
| Market Cap (mil) | 17,533.90 |
| Beta | 0.78 |
| Outstanding shares (mil) | 620.23 |
| Enterprise Value (mil) | 24,786.90 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.63% |
| Cost of Debt | 6.81% |
| WACC | 7.34% |